The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oncology Based Molecular Diagnostics Market Research Report 2025

Global Oncology Based Molecular Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1466135

No of Pages : 79

Ask Your Query

Synopsis

Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor.

The global Oncology Based Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oncology Based Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Based Molecular Diagnostics.

Report Scope

The Oncology Based Molecular Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncology Based Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology Based Molecular Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Abbott Laboratories
  • Bayer Healthcare
  • Becton Dickinson
  • Cepheid
  • Dako
  • Danaher Corporation
  • Gen Probe(Hologic)
  • Roche Diagnostics
  • Siemens Healthcare

Segment by Type

  • PCR
  • Multiplex PCR
  • In Situ Hybridization
  • Isothermal Nucleic Acid Amplification Technology (INAAT)

Segment by Application

  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oncology Based Molecular Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oncology Based Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Oncology Based Molecular Diagnostics Market Overview
1.1 Product Overview and Scope of Oncology Based Molecular Diagnostics
1.2 Oncology Based Molecular Diagnostics Segment by Type
1.2.1 Global Oncology Based Molecular Diagnostics Market Value Comparison by Type (2024-2030)
1.2.2 PCR
1.2.3 Multiplex PCR
1.2.4 In Situ Hybridization
1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Oncology Based Molecular Diagnostics Segment by Application
1.3.1 Global Oncology Based Molecular Diagnostics Market Value by Application: (2024-2030)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Other
1.4 Global Oncology Based Molecular Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Oncology Based Molecular Diagnostics Revenue 2019-2030
1.4.2 Global Oncology Based Molecular Diagnostics Sales 2019-2030
1.4.3 Global Oncology Based Molecular Diagnostics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oncology Based Molecular Diagnostics Market Competition by Manufacturers
2.1 Global Oncology Based Molecular Diagnostics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oncology Based Molecular Diagnostics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oncology Based Molecular Diagnostics Average Price by Manufacturers (2019-2024)
2.4 Global Oncology Based Molecular Diagnostics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oncology Based Molecular Diagnostics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Based Molecular Diagnostics, Product Type & Application
2.7 Oncology Based Molecular Diagnostics Market Competitive Situation and Trends
2.7.1 Oncology Based Molecular Diagnostics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oncology Based Molecular Diagnostics Players Market Share by Revenue
2.7.3 Global Oncology Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Based Molecular Diagnostics Retrospective Market Scenario by Region
3.1 Global Oncology Based Molecular Diagnostics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oncology Based Molecular Diagnostics Global Oncology Based Molecular Diagnostics Sales by Region: 2019-2030
3.2.1 Global Oncology Based Molecular Diagnostics Sales by Region: 2019-2024
3.2.2 Global Oncology Based Molecular Diagnostics Sales by Region: 2025-2030
3.3 Global Oncology Based Molecular Diagnostics Global Oncology Based Molecular Diagnostics Revenue by Region: 2019-2030
3.3.1 Global Oncology Based Molecular Diagnostics Revenue by Region: 2019-2024
3.3.2 Global Oncology Based Molecular Diagnostics Revenue by Region: 2025-2030
3.4 North America Oncology Based Molecular Diagnostics Market Facts & Figures by Country
3.4.1 North America Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oncology Based Molecular Diagnostics Sales by Country (2019-2030)
3.4.3 North America Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oncology Based Molecular Diagnostics Market Facts & Figures by Country
3.5.1 Europe Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oncology Based Molecular Diagnostics Sales by Country (2019-2030)
3.5.3 Europe Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology Based Molecular Diagnostics Market Facts & Figures by Country
3.6.1 Asia Pacific Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oncology Based Molecular Diagnostics Sales by Country (2019-2030)
3.6.3 Asia Pacific Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oncology Based Molecular Diagnostics Market Facts & Figures by Country
3.7.1 Latin America Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oncology Based Molecular Diagnostics Sales by Country (2019-2030)
3.7.3 Latin America Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology Based Molecular Diagnostics Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology Based Molecular Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oncology Based Molecular Diagnostics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oncology Based Molecular Diagnostics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oncology Based Molecular Diagnostics Sales by Type (2019-2030)
4.1.1 Global Oncology Based Molecular Diagnostics Sales by Type (2019-2024)
4.1.2 Global Oncology Based Molecular Diagnostics Sales by Type (2025-2030)
4.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Type (2019-2030)
4.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2019-2030)
4.2.1 Global Oncology Based Molecular Diagnostics Revenue by Type (2019-2024)
4.2.2 Global Oncology Based Molecular Diagnostics Revenue by Type (2025-2030)
4.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Type (2019-2030)
4.3 Global Oncology Based Molecular Diagnostics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oncology Based Molecular Diagnostics Sales by Application (2019-2030)
5.1.1 Global Oncology Based Molecular Diagnostics Sales by Application (2019-2024)
5.1.2 Global Oncology Based Molecular Diagnostics Sales by Application (2025-2030)
5.1.3 Global Oncology Based Molecular Diagnostics Sales Market Share by Application (2019-2030)
5.2 Global Oncology Based Molecular Diagnostics Revenue by Application (2019-2030)
5.2.1 Global Oncology Based Molecular Diagnostics Revenue by Application (2019-2024)
5.2.2 Global Oncology Based Molecular Diagnostics Revenue by Application (2025-2030)
5.2.3 Global Oncology Based Molecular Diagnostics Revenue Market Share by Application (2019-2030)
5.3 Global Oncology Based Molecular Diagnostics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Oncology Based Molecular Diagnostics Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Bayer Healthcare
6.2.1 Bayer Healthcare Corporation Information
6.2.2 Bayer Healthcare Description and Business Overview
6.2.3 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Healthcare Oncology Based Molecular Diagnostics Product Portfolio
6.2.5 Bayer Healthcare Recent Developments/Updates
6.3 Becton Dickinson
6.3.1 Becton Dickinson Corporation Information
6.3.2 Becton Dickinson Description and Business Overview
6.3.3 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Becton Dickinson Oncology Based Molecular Diagnostics Product Portfolio
6.3.5 Becton Dickinson Recent Developments/Updates
6.4 Cepheid
6.4.1 Cepheid Corporation Information
6.4.2 Cepheid Description and Business Overview
6.4.3 Cepheid Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cepheid Oncology Based Molecular Diagnostics Product Portfolio
6.4.5 Cepheid Recent Developments/Updates
6.5 Dako
6.5.1 Dako Corporation Information
6.5.2 Dako Description and Business Overview
6.5.3 Dako Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dako Oncology Based Molecular Diagnostics Product Portfolio
6.5.5 Dako Recent Developments/Updates
6.6 Danaher Corporation
6.6.1 Danaher Corporation Corporation Information
6.6.2 Danaher Corporation Description and Business Overview
6.6.3 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Danaher Corporation Oncology Based Molecular Diagnostics Product Portfolio
6.6.5 Danaher Corporation Recent Developments/Updates
6.7 Gen Probe(Hologic)
6.6.1 Gen Probe(Hologic) Corporation Information
6.6.2 Gen Probe(Hologic) Description and Business Overview
6.6.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product Portfolio
6.7.5 Gen Probe(Hologic) Recent Developments/Updates
6.8 Roche Diagnostics
6.8.1 Roche Diagnostics Corporation Information
6.8.2 Roche Diagnostics Description and Business Overview
6.8.3 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Diagnostics Oncology Based Molecular Diagnostics Product Portfolio
6.8.5 Roche Diagnostics Recent Developments/Updates
6.9 Siemens Healthcare
6.9.1 Siemens Healthcare Corporation Information
6.9.2 Siemens Healthcare Description and Business Overview
6.9.3 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Siemens Healthcare Oncology Based Molecular Diagnostics Product Portfolio
6.9.5 Siemens Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology Based Molecular Diagnostics Industry Chain Analysis
7.2 Oncology Based Molecular Diagnostics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology Based Molecular Diagnostics Production Mode & Process
7.4 Oncology Based Molecular Diagnostics Sales and Marketing
7.4.1 Oncology Based Molecular Diagnostics Sales Channels
7.4.2 Oncology Based Molecular Diagnostics Distributors
7.5 Oncology Based Molecular Diagnostics Customers
8 Oncology Based Molecular Diagnostics Market Dynamics
8.1 Oncology Based Molecular Diagnostics Industry Trends
8.2 Oncology Based Molecular Diagnostics Market Drivers
8.3 Oncology Based Molecular Diagnostics Market Challenges
8.4 Oncology Based Molecular Diagnostics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock